Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pileri

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
The Journal of Pathology|January 30, 1999
Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphomaE Pilozzi, K Pulford, M Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2009
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patientsE Derenzini, M P Fina, V Stefoni, et al.
Blood|November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)B Falini, L Flenghi, M Fagioli, et al.
Leukemia|April 20, 2007
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomasB Falini, D Lenze, R Hasserjian, et al.
Blood|November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALKB Falini, K Pulford, A Pucciarini, et al.
Blood|March 9, 2000
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsB Falini, M Fizzotti, A Pucciarini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth controlL Leoncini, C Bellan, A Cossu, et al.
International Journal of Cancer|June 8, 2000
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activityL Leoncini, S Lazzi, D Scano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2008
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patientsP L Zinzani, M Tani, S Fanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
The Journal of Pathology|January 30, 1999
Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphomaE Pilozzi, K Pulford, M Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2009
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patientsE Derenzini, M P Fina, V Stefoni, et al.
Blood|November 14, 1997
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)B Falini, L Flenghi, M Fagioli, et al.
Leukemia|April 20, 2007
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomasB Falini, D Lenze, R Hasserjian, et al.
Blood|November 24, 1999
Lymphomas expressing ALK fusion protein(s) other than NPM-ALKB Falini, K Pulford, A Pucciarini, et al.
Blood|March 9, 2000
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsB Falini, M Fizzotti, A Pucciarini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth controlL Leoncini, C Bellan, A Cossu, et al.
International Journal of Cancer|June 8, 2000
Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activityL Leoncini, S Lazzi, D Scano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2008
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patientsP L Zinzani, M Tani, S Fanti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Pageof 25